Mingozzi, F., Buning, H. :
Adeno-Associated Viral Vectors at the Frontier between Tolerance and Immunity
Front Immunol, 2015 ; 6 : 120
Publications (1184)
Wary, C., Azzabou, N., Giraudeau, C., Le Louer, J., Montus, M., Voit, T., Servais, L., Carlier, P. :
Quantitative NMRI and NMRS identify augmented disease progression after loss of ambulation in forearms of boys with Duchenne muscular dystrophy NMR Biomed, 2015 ; 28 (9) : 1150-62
Quantitative NMRI and NMRS identify augmented disease progression after loss of ambulation in forearms of boys with Duchenne muscular dystrophy NMR Biomed, 2015 ; 28 (9) : 1150-62
Allamand, V. :
Genetique Med Sci (Paris), 2015 ; 31 Spec No 3 : 28-9
Genetique Med Sci (Paris), 2015 ; 31 Spec No 3 : 28-9
Hamel, Y., Mamoune, A., Mauvais, F. X., Habarou, F., Lallement, L., Romero, N. B., Ottolenghi, C., de Lonlay, P. :
Acute rhabdomyolysis and inflammation J Inherit Metab Dis, 2015 ; 38 (4) : 621-628
Acute rhabdomyolysis and inflammation J Inherit Metab Dis, 2015 ; 38 (4) : 621-628
Tuzun, E., Berrih-Aknin, S., Brenner, T., Kusner, L. L., Le Panse, R., Yang, H., Tzartos, S., Christadoss, P. :
Guidelines for standard preclinical experiments in the mouse model of myasthenia gravis induced by acetylcholine receptor immunization Exp Neurol, 2015 ; 270 : 11-17
Guidelines for standard preclinical experiments in the mouse model of myasthenia gravis induced by acetylcholine receptor immunization Exp Neurol, 2015 ; 270 : 11-17
de la Vaissiere, S., Toutain, A., Chene, M. A., Lagrue, E., Cantagrel, S., Provost, S., Eymard, B., Castelnau, P. :
Syndromes myastheniques congenitaux de l’enfant : strategies therapeutiques medicamenteuses Arch Pediatr, 2015 ; 22 (7) : 724-8
Syndromes myastheniques congenitaux de l’enfant : strategies therapeutiques medicamenteuses Arch Pediatr, 2015 ; 22 (7) : 724-8
Wirth, B., Barkats, M., Martinat, C., Sendtner, M., Gillingwater, T. H. :
Moving towards treatments for spinal muscular atrophy: hopes and limits Expert Opin Emerg Drugs, 2015 ; 20 (3) : 353-6
Moving towards treatments for spinal muscular atrophy: hopes and limits Expert Opin Emerg Drugs, 2015 ; 20 (3) : 353-6
Mercier, S., Kury, S., Salort-Campana, E., Magot, A., Agbim, U., Besnard, T., Bodak, N., Bou-Hanna, C., Breheret, F., Brunelle, P., Caillon, F., Chabrol, B., Cormier-Daire, V., David, A., Eymard, B., Faivre, L., Figarella-Branger, D., Fleurence, E., Ganapathi, M., Gherardi, R., Goldenberg, A., Hamel, A., Igual, J., Irvine, A. D., Israel-Biet, D., Kannengiesser, C., Laboisse, C., Le Caignec, C., Mahe, J. Y., Mallet, S., MacGowan, S., McAleer, M. A., McLean, I., Meni, C., Munnich, A., Mussini, J. M., Nagy, P. L., Odel, J., O'Regan, G. M., Pereon, Y., Perrier, J., Piard, J., Puzenat, E., Sampson, J. B., Smith, F., Soufir, N., Tanji, K., Thauvin, C., Ulane, C., Watson, R. M., Khumalo, N. P., Mayosi, B. M., Barbarot, S., Bezieau, S. :
Expanding the clinical spectrum of hereditary fibrosing poikiloderma with tendon contractures, myopathy and pulmonary fibrosis due to FAM111B mutations Orphanet J Rare Dis, 2015 ; 10 : 135
Expanding the clinical spectrum of hereditary fibrosing poikiloderma with tendon contractures, myopathy and pulmonary fibrosis due to FAM111B mutations Orphanet J Rare Dis, 2015 ; 10 : 135
Allenbach, Y, Guiguet, M, Rigolet, A, Marie, I, Hachulla, E, Drouot, L, Jouen, F, Jacquot, S, Mariampillai, K, Musset, L, Grenier, P, Devilliers, H, Hij, A, Boyer, O, Herson, S, Benveniste, O :
Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti- Synthetase Auto-Antibodies: an Open-Label, Phase II Trial PLoS ONE, 2015 ; (SP) :
Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti- Synthetase Auto-Antibodies: an Open-Label, Phase II Trial PLoS ONE, 2015 ; (SP) :
Maurer, M., Bougoin, S., Feferman, T., Frenkian, M., Bismuth, J., Mouly, V., Clairac, G., Tzartos, S., Fadel, E., Eymard, B., Fuchs, S., Souroujon, M. C., Berrih-Aknin, S. :
IL-6 and Akt are involved in muscular pathogenesis in myasthenia gravis Acta Neuropathol Commun, 2015 ; 3 (1) : 1
IL-6 and Akt are involved in muscular pathogenesis in myasthenia gravis Acta Neuropathol Commun, 2015 ; 3 (1) : 1
